Company intelligence / Profile preview

B-Secur

Belfast, Northern Ireland, United Kingdomb-secur.com ↗

Ownership: Private
Development stage: Commercial

Overview

B-Secur’s HeartKey® suite has received multiple FDA clearances. The latest product, HeartKey® Rhythm, provides advanced ambulatory ECG analysis with high signal clarity for improved clinical confidence. The technology enables earlier detection of actionable cardiac conditions in both medical-grade devices and consumer wearables. No traditional “clinical results” as it’s a diagnostics/software platform.

Therapeutic areas: Cardiovascular
Modalities: DeviceSoftware/Algorithm (ECG/EKG signal processing and analytics)
Industry: Digital Health Medical Devices

Partnerships

Biotricity Inc. – partnership to deliver integrated ambulatory cardiac monitoring platforms in the USMaxim Integrated Products – collaboration to integrate ECG algorithms into sensor hubs for wearables

Beyond the preview

Go deeper on B-Secur.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on B-Secur.

Explore the full profile